New Psychoactive Substance Market size was valued at USD 2.4 Billion in 2024 and is projected to reach USD 4.8 Billion by 2033, exhibiting a CAGR of 8.3% from 2026 to 2033.
The global New Psychoactive Substance (NPS) market was valued at approximately USD 62.3 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030. This growth is driven by increasing recreational drug usage, the proliferation of synthetic drugs, and the rapid evolution of novel psychoactive compounds that often evade regulation. Government agencies and healthcare bodies are closely monitoring the rise in synthetic stimulants, cannabinoids, and hallucinogens. The expanding global footprint of online drug distribution networks has further accelerated market penetration, particularly in North America and Europe, where consumption and law enforcement challenges are prominent. North America accounted for the largest share of the NPS market in 2022, driven by rising awareness, high consumption rates, and increasing incidence of substance abuse cases.
Europe followed North America in terms of market share, propelled by increased monitoring by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and rising detection of new variants in the region. Asia Pacific is anticipated to witness the fastest CAGR during the forecast period due to changing regulatory policies, rising urbanization, and an increase in cross border trafficking. The Middle East and Africa and Latin America represent emerging opportunities with growing awareness campaigns and surveillance efforts. The market landscape presents significant opportunities in forensic toxicology, law enforcement, and healthcare diagnostics, with increasing demand for rapid drug testing kits and early detection technologies. Additionally, research and development investments in pharmacovigilance and drug profiling continue to create openings for data driven interventions and policy planning across regions facing high drug related health burdens.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=400274&utm_source=Pulse_G_April&utm_medium=212
Â
Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=400274&utm_source=Pulse_G_April&utm_medium=212
Growing demand for below applications around the world has had a direct impact on the growth of the Global New Psychoactive Substance Market
Powder
Capsules
Tablets
Liquids
Stimulants
Hallucinogens
Depressants
Opioids
Others
Oral
Inhalation
Injection
Transdermal
Recreational Users
Medical Use
Research Laboratories
Online
Offline
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/new-psychoactive-substance-market/
1. Introduction of the Global New Psychoactive Substance Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global New Psychoactive Substance Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global New Psychoactive Substance Market, By Type
6. Global New Psychoactive Substance Market, By Application
7. Global New Psychoactive Substance Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global New Psychoactive Substance Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/